Strategy to prevent neonatal early-onset group B streptococcal (GBS) disease in the Netherlands

Reviews and Research in Medical Microbiology

Volumn 14, Issue 1, 2003, Pages 35-39

  Trijbels Smeulders, Monique A J M ^a   Adriaanse, Albert H ^b   Gerards, Leo J ^c   Kimpenc, Jan L L ^c  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Location Alkmaar   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Group B streptococcal disease; Neonates; Prevention strategy

Indexed keywords

AMOXICILLIN; AMPICILLIN; CHLORHEXIDINE; CLINDAMYCIN; ERYTHROMYCIN; PENICILLIN G; POLYSACCHARIDE VACCINE;

ANTIBIOTIC PROPHYLAXIS; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; CHEMOPROPHYLAXIS; DELIVERY; DIAGNOSTIC PROCEDURE; DISINFECTION; EUROPE; HUMAN; IMMUNIZATION; INFECTION PREVENTION; INFECTION RISK; NETHERLANDS; NEWBORN INFECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; UNITED STATES;

EID: 0037241638     PISSN: 0954139X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00013542-200301000-00004     Document Type: Review

References (36)

1. CDC. Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR 1996; 45(RR-7):1-24.
2. American Academy of Paediatrics, Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. Paediatrics 1997; 99:489-496.
3. Schrag S, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 2000; 342: 15-20.
4. Trijbels-Smeulders M, Gerards LJ, Pasker-de Jong PCM, van Lingen RA, Adriaanse AH, de Jonge GA, et al. Epidemiology of neonatal group B streptococcal disease in the Netherlands 1997-1998. Paediatr Perinatal Epidemiol 2002; 16:334-341.
5. Schuchat A, Wenger JD. Epidemiology of group B streptococcal disease. Epidemiol Rev 1994; 16:374-402.
6. Boyer KM, Gadzala CA, Kelly PD, Burd LI, Gotoff SP. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. Predictive value of prenatal cultures. J Infect Dis 1983; 148:802-809.
7. Hoogkamp-Korstanje JAA, Gerards LJ, Cats BP. Maternal carriage and neonatal acquisition of group B streptococci. J Infect Dis 1982; 145:800-803.
8. Adriaanse AH. Prevention of neonatal septicaemia due to group B streptococci. Ballieries Clin Obstet Gynaecol 1995; 9:545-552.
9. Bramer S, van Wijk F, Mol B, Adriaanse AH. Risk indicators for neonatal early-onset GBS related disease. A case-control study. J Perinat Med 1997; 25:469-475.
10. Schuchat A, Deaver-Robinson K, Plikaytis B. Multistate case-control study of maternal risk factors for neonatal group B streptococcal disease. Pediatr Infect Dis J 1994; 13:623-629.
11. Zangwill KM, Schuchat A, Wenger JD. Group B streptococcal disease in the United States 1990:report from a multistate active surveillance system. MMWR CDC Surveill Summ 1992; 41: 25-32.
12. Mayon-White RT. The incidence of GBS disease in neonates in different countries. Antibiot Chemother 1985; 35:17-27.
13. Aavitsland P, Hoiby E, Lystad A. Systemic group B streptococcal disease in neonates and young infants in Norway 1985-94. Acta Paediatr 1996; 85:104-105.
14. Moses L, Heath P, Wilkinson A, Jeffery H, Isaacs D. Early onset group B streptococcal neonatal infection in Oxford 1985-96. Arch Dis Child Fetal Neonatal Ed 1998; 79:F148-F149.
15. Bignardi G. Surveillance of neonatal group B streptococcal infection in Sunderland. Commun Dis Public Health 1999; 2:64-65.
16. Schuchat A. Neonatal group B streptococcal disease. Screening and prevention. N Engl J Med 2000; 343:209-210.
17. Dillon HC, Gray E, Pass MA, Gray BM. Anorectal and vaginal carriage of group B streptococci during pregnancy. J Infect Dis 1982; 145:794-799.
18. Baker CJ, Goroff DK, Alpert S. Vaginal colonisation with group B streptococcus: a study of college women. J Infect Dis 1977; 135:392-397.
19. Adriaanse AH, Muytjens HL, Kollée LAA, Nijhuis JG, Eskes TKAB. Sensitivity of intrapartum group B streptococcal screening and in vitro comparison of four rapid antigen tests. Eur J Obstet Gynecol Reprod Biol 1994; 56:21-26.
20. Park CH, Ruprai D, Vandel NM, Hixon DL, Mecklenburg FE. Rapid detection of group B streptococcal antigen from vaginal specimens using a new optical immunoassay technique. Diagn Microbiol Infect Dis 1996; 24:125-128.
21. Bergeron MG, Danbing KE, Menard D. Rapid detection of group B streptococci in pregnant women at delivery. N Engl J Med 2000; 343:175.
22. Boyer KM, Gotoff SP. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med 1986; 314:1665-1669.
23. Allen UD, Navas L, King SM. Effectiveness of intrapartum penicillin prophylaxis in preventing early-onset group B streptococcal infection: results of a meta-analysis. Can Med Assoc J 1993; 149:1659-1665.
24. Amstey MS, Gibbs RS. Is penicillin G a better choice than ampicillin for prophylaxis of neonatal group B streptococcal infections? Obstet Gynecol 1994; 84:1058-1059.
25. Adriaanse AH, Kollée LAA, Muytjens HL, Nijhuis JG, de Haan AFJ, Eskes TKAB. Randomised study of vaginal chlorhexidine disinfection during labour to prevent vertical transmission of group B streptococci. Eur J Obstet Gynecol Reprod Biol 1995; 61:135-141.
26. Burman LG, Christensen P, Christensen K. Prevention of excess neonatal morbidity associated with group B streptococci by vaginal chlorhexidine disinfection during labour. The Swedish Chlorhexidine Study Group. Lancet 1992; 340:65-69.
27. Taha ET, Biggar RJ, Broadhead RL. Effect of cleansing the birth canal with antiseptic solution on maternal and newborn morbidity and mortality in Malawi: clinical trial. BMJ 1997; 315: 216-219.
28. Schuchat A, Wenger JD. Epidemiology of group B streptococcal disease: risk factors, prevention strategies and vaccine development. Epidemiol Rev 1994; 16:374-402.
29. Kasper DL, Paoletti LC, Wessels MR. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. J Clin Invest 1996; 98:2308-2314.
30. Baker CJ, Paoletti LC, Wessels MR. Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib. J Infect Dis 1999; 179:142-150.
31. Baker CJ, Paoletti LC, Rench MA. Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B streptococcus in healthy women. J Infect Dis 2000; 182:1129-1138.
32. Rouse DJ, Goldenberg RL, Cliver SP. Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: a decision analysis. Obstet Gynecol 1994; 83:483-494.
33. CDC. Prevention of perinatal group B streptococcal disease: revised guidelines from CDC. MMWR 2002; 51 (RR-11):1-24.
34. Schrag SJ, Phil D, Zell ER. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med 2002; 347:233-239.
35. Fernandez M, Hickman ME, Baker CJ. Antimicrobiol susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis. Antimicrob Agents Chemother 1998; 42:1517-1519.
36. Mohle-Boetani JC, Schuchat A, Plikaytis BD. Comparison of prevention strategies for neonatal group B streptococcal infection: a population-based economic analysis. JAMA 1993; 270:1442-1448.